Published in partnership with the

Logo

Club Jules Gonin

Experimental studies on nonpenetrating filtration surgery using the CO2 laser

Ehud I. Assia, Yigal Rotenstreich, Irina S. Barequet, David J. Apple, Mordechai Rosner and Michael Belkin

View Related Documents

Abstract

Background  

This study evaluated the use of a CO2 laser for performing deep sclerectomy in nonpenetrating filtration surgery.

Methods  

Three experimental models were performed: enucleated sheep and cow eyes (n=18) to determine optimal irradiation parameters, live rabbit eyes (n=20) to test feasibility, and cadaver eyes (40 procedures in 20 eyes) to study effects in human eyes tissue. After a half-thickness scleral flap was created, deep sclerectomy was performed by CO2 laser applications on the scleral bed down to the trabeculo-Descemet’s membrane.

Results  

Fluid percolation was repeatedly achieved without penetration in sheep and cow eyes using scanned laser energy of 5–10 W at a pulse duration of 200 μs and a working distance of 35 cm. In live rabbits, deep sclerectomy was achieved without perforation in 19/20 eyes. Intraocular pressure was significantly decreased on the first postoperative day (10.3±5.1 mmHg lower, on average, than in the nonoperated fellow eye; P<0.001), and this persisted for 21 days. Operations on all cadaver eyes resulted in effective fluid percolation. Penetration of the scleral wall occurred in five cases only after repeated laser applications with high energy. Histologically, a thin sclerocorneal intact wall was demonstrated at the sclerectomy bed. Collateral tissue damage did not extend beyond 100 μm, and adjacent structures remained unharmed.

Conclusions  

CO2 laser-assisted deep sclerectomy is a feasible and apparently safe procedure.

Keywords  Trabeculectomy - Sclerectomy - Penetrating filter surgery

Optomedic Ltd, Or-Yehuda, Israel, which does no longer exists, sponsored this study. Drs. Assia, Barequet and Belkin were paid consultants of Optomedic Ltd. Currently, the IP of the device belongs to OptoTech Ltd, Nazareth, Israel. Dr. Assia is the medical director of OptoTech Ltd.

Fulltext Preview

Image of the first page of the fulltext document